Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06227117
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-01-17
Brief Title:
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative HER2 Low-expressing Breast Cancer
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd
Organization Data
Organization:
RemeGen Co Ltd
Class:
INDUSTRY
Study ID:
RC48-C024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RemeGen Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None